Literature DB >> 26152231

Community-directed interventions are practical and effective in low-resource communities: experience of ivermectin treatment for onchocerciasis control in Cameroon and Uganda, 2004-2010.

Moses N Katabarwa1, Peace Habomugisha2, Albert Eyamba3, Edson Byamukama2, Philippe Nwane3, Alex Arinaitwe4, Julius Musigire5, Ruth Tushemereirwe6, Annet Khainza2.   

Abstract

BACKGROUND: The community-directed intervention (CDI) approach has improved treatment coverage in onchocerciasis-affected communities. However, there is still a lot to learn. This study assessed its performance and highlighted the lessons learnt so far.
METHODS: Representative samples of households were selected from Cameroon and Uganda program areas through multi-stage random sampling. An adult male and female from every selected household were interviewed separately on their involvement in CDI activities every year between 2004 and 2010. Community health workers (CHWs) were interviewed and treatment records reviewed to determine whether 90% treatment coverage was attained within 2 weeks. Records related to training of CHWs and their supervisors were analyzed.
RESULTS: Decision making decreased for community leaders and health workers, while it increased for community members. The proportion of CHWs attaining 90% treatment coverage within 2 weeks improved as their demand for monetary incentives, and number of persons they served, reduced. The number of CHWs supervised by a community supervisor remained low, but increased for the health workers. The cost of training a CHW and a community supervisor reduced to about US$1 and US$4.8, respectively.
CONCLUSIONS: The CDI approach was effective, culturally appropriate and probably less costly in delivering health services in low-resource communities.
© The Author 2015. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Cameroon; Community-directed interventions; Ivermectin; Low-resource communities; Onchocerciasis; Uganda

Mesh:

Substances:

Year:  2015        PMID: 26152231     DOI: 10.1093/inthealth/ihv038

Source DB:  PubMed          Journal:  Int Health        ISSN: 1876-3405            Impact factor:   2.473


  11 in total

1.  Presence of Wuchereria bancrofti microfilaremia despite 7 years of annual ivermectin monotherapy mass drug administration for onchocerciasis control: a study in north-west Ethiopia.

Authors:  Tekola Endeshaw; Aseged Taye; Zerihun Tadesse; Moses N Katabarwa; Oumer Shafi; Tewodros Seid; Frank O Richards
Journal:  Pathog Glob Health       Date:  2015       Impact factor: 2.894

2.  Comparison of Reported and Survey-Based Coverage in Onchocerciasis Programs over a Period of 8 Years in Cameroon and Uganda.

Authors:  Moses N Katabarwa; Emily Griswold; Peace Habomugisha; Albert Eyamba; Edson Byamukama; Philippe Nwane; Annet Khainza; Lauri Bernard; Paul Weiss; Frank O Richards
Journal:  Am J Trop Med Hyg       Date:  2019-05       Impact factor: 2.345

3.  Impact of community-based health insurance on utilisation of preventive health services in rural Uganda: a propensity score matching approach.

Authors:  Emmanuel Nshakira-Rukundo; Essa Chanie Mussa; Nathan Nshakira; Nicolas Gerber; Joachim von Braun
Journal:  Int J Health Econ Manag       Date:  2021-02-10

4.  Audit of the community-directed treatment with ivermectin (CDTI) for onchocerciasis and factors associated with adherence in three regions of Cameroon.

Authors:  Guy-Roger Kamga; Fanny N Dissak-Delon; Hugues C Nana-Djeunga; Benjamin D Biholong; Stephen Mbigha Ghogomu; Jacob Souopgui; Joseph Kamgno; Annie Robert
Journal:  Parasit Vectors       Date:  2018-06-19       Impact factor: 4.047

5.  Evaluation of Treatment Coverage and Enhanced Mass Drug Administration for Onchocerciasis and Lymphatic Filariasis in Five Local Government Areas Treating Twice Per Year in Edo State, Nigeria.

Authors:  Emily Griswold; Abel Eigege; Cephas Ityonzughul; Emmanuel Emukah; Emmanuel S Miri; Ifeoma Anagbogu; Yisa A Saka; Saliu Kadiri; Solomon Adelamo; Paul Ugbadamu; Clement Ikogho; Frank O Richards
Journal:  Am J Trop Med Hyg       Date:  2018-06-21       Impact factor: 3.707

6.  Important progress towards elimination of onchocerciasis in the West Region of Cameroon.

Authors:  Guy-Roger Kamga; Fanny N Dissak-Delon; Hugues C Nana-Djeunga; Benjamin D Biholong; Stephen Mbigha Ghogomu; Jacob Souopgui; Joseph Kamgno; Annie Robert
Journal:  Parasit Vectors       Date:  2017-08-03       Impact factor: 3.876

7.  The Galabat-Metema cross-border onchocerciasis focus: The first coordinated interruption of onchocerciasis transmission in Africa.

Authors:  Moses N Katabarwa; Isam M A Zarroug; Nebiyu Negussu; Nabil M Aziz; Zerihun Tadesse; Wigdan A Elmubark; Zainab Shumo; Kadu Meribo; Hashim Kamal; Aderajew Mohammed; Yewondwossen Bitew; Tewodros Seid; Firdaweke Bekele; Abebual Yilak; Tekola Endeshaw; Mohammed Hassen; Abate Tillahun; Fikresilasie Samuel; Henok Birhanu; Tadesse Asmare; Daniel Boakye; Sindew M Feleke; Thomas Unnasch; Rory Post; Tarig Higazi; Emily Griswold; Charles Mackenzie; Frank Richards
Journal:  PLoS Negl Trop Dis       Date:  2020-02-06

8.  Effect of Ivermectin Treatment on the Frequency of Seizures in Persons with Epilepsy Infected with Onchocerca volvulus.

Authors:  Alfred Dusabimana; Solomon Tsebeni Wafula; Stephen Jada Raimon; Joseph Nelson Siewe Fodjo; Dan Bhwana; Floribert Tepage; Gasim Abd-Elfarag; An Hotterbeekx; Steven Abrams; Robert Colebunders
Journal:  Pathogens       Date:  2020-12-31

9.  From river blindness control to elimination: bridge over troubled water.

Authors:  Robert Colebunders; Maria-Gloria Basáñez; Katja Siling; Rory J Post; Anke Rotsaert; Bruno Mmbando; Patrick Suykerbuyk; Adrian Hopkins
Journal:  Infect Dis Poverty       Date:  2018-03-28       Impact factor: 4.520

10.  Valuing the Unpaid Contribution of Community Health Volunteers to Mass Drug Administration Programs.

Authors:  Hugo C Turner; Jaspreet Toor; Alison A Bettis; Adrian D Hopkins; Shwe Sin Kyaw; Obinna Onwujekwe; Guy E Thwaites; Yoel Lubell; Christopher Fitzpatrick
Journal:  Clin Infect Dis       Date:  2019-04-24       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.